Report cover image

Dental Radiology Equipment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Published Sep 04, 2025
Length 200 Pages
SKU # FCSL20372264

Description

Fairfield Market Research has recently published an in-depth report on the global Dental Radiology Equipment Market, offering a thorough analysis of the industry’s growth drivers, challenges, emerging trends, and opportunities. The study provides valuable insights to help stakeholders make strategic business decisions.

Market Insights

The global dental radiology equipment market size is projected to be US$ 3.4 Bn in 2025, reaching approximately US$ 5.5 Bn by 2032, at a steady CAGR of 7.11% over the forecast period. Growth is primarily driven by the increasing need for precise dental diagnostics, coupled with rising oral health awareness worldwide. The adoption of advanced imaging technologies, expansion of dental care facilities, and integration of AI-based diagnostic systems are accelerating demand for modern radiology solutions.

Dental Radiology Equipment Market – Report Scope

The dental radiology equipment market covers a wide range of imaging systems, including intraoral and extraoral X-rays, CBCT imaging, and plate scanners. These tools are vital for accurate diagnosis, treatment planning, and follow-ups in dentistry. The transition from film-based imaging to digital radiology has enhanced efficiency, lowered radiation risks, and improved diagnostic quality. Continuous product innovations, alongside the rising trend of preventive dental care, are key factors shaping the market’s evolution.

Market Growth Drivers

Growing prevalence of dental diseases, including cavities and periodontal conditions, has boosted the demand for advanced imaging technologies. Rising geriatric population with higher susceptibility to oral health issues also supports market expansion. In addition, the shift toward minimally invasive dentistry, combined with AI-powered diagnostic imaging, is transforming dental practices. Increased government support for oral healthcare programs and the rise of dental tourism in emerging economies further contribute to strong market growth.

Market Restraints

High equipment costs and ongoing maintenance expenses remain key barriers, particularly for smaller dental clinics and practices in low-income regions. Limited access to advanced dental care in certain developing economies further restricts adoption. A shortage of trained professionals capable of operating advanced radiology systems also hampers growth. Moreover, despite improvements in digital systems, lingering concerns regarding radiation exposure continue to affect patient acceptance in some markets.

Market Opportunities

Rapid adoption of cone-beam computed tomography (CBCT) and 3D imaging technologies presents strong growth opportunities, especially in orthodontics and implant dentistry. AI-based diagnostic platforms and cloud-enabled imaging solutions are enhancing accuracy and efficiency, opening new revenue streams for manufacturers. Emerging economies in Asia-Pacific and Latin America are becoming high-potential markets due to rising dental care infrastructure and increasing disposable incomes. Collaborations with dental service providers and innovation in portable, cost-effective radiology systems are expected to accelerate market penetration.

Regional Outlook

North America holds the largest market share, backed by advanced healthcare infrastructure, strong adoption of digital technologies, and growing prevalence of dental diseases. Europe remains a key market due to favorable healthcare policies and high awareness of oral health. Asia Pacific is forecast to grow the fastest, supported by the expansion of dental tourism, rapid urbanization, and rising healthcare spending in countries like China, India, and Thailand. Latin America and the Middle East & Africa also show potential as awareness of modern dental practices increases.

Leading Companies

Key companies driving innovation and competition in the dental radiology equipment market include:
• ACTEON
• Carestream Health, Inc.
• Danaher Corporation
• Dentsply Sirona
• Midmark Corporation
• Planmeca Oy
• VATECH
• Apteryx Imaging Inc.
• KaVo
• CALCIVIS
• Envista
• The Yoshida Dental Mfg. Co. Ltd

Market Segmentation

By Type:
• Extraoral X-Ray Systems
• Intraoral X-Ray Systems
• Intraoral Plate Scanners
• Cone-Beam Computed Tomography (CBCT) Imaging

By Application:
• Hospitals
• Dental Clinics
• Ambulatory Surgical Centers

By Region:
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa

Please note: Delivery Timelines - 5 working days.

Table of Contents

200 Pages
1. Executive Summary
1.1. Global Biosimulation Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2025
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Biosimulation Market Outlook, 2019-2032
3.1. Global Biosimulation Market Outlook, by Product, Value (US$ Bn), 2019-2032
3.1.1. Key Highlights
3.1.1.1. Software
3.1.1.2. Services
3.2. Global Biosimulation Market Outlook, by Application, Value (US$ Bn), 2019-2032
3.2.1. Key Highlights
3.2.1.1. Drug Development
3.2.1.2. Drug Discovery
3.2.1.3. Other Applications
3.3. Global Biosimulation Market Outlook, by End User, Value (US$ Bn), 2019-2032
3.3.1. Key Highlights
3.3.1.1. Academic and Government Research Institutes
3.3.1.2. Pharmaceutical and Biotech Companies
3.3.1.3. Contract Research Organizations
3.3.1.4. Regulatory Authorities
3.3.1.5. Other End Users
3.4. Global Biosimulation Market Outlook, by Region, Value (US$ Bn), 2019-2032
3.4.1. Key Highlights
3.4.1.1. North America
3.4.1.2. Europe
3.4.1.3. Asia Pacific
3.4.1.4. Latin America
3.4.1.5. Middle East & Africa
4. North America Biosimulation Market Outlook, 2019-2032
4.1. North America Biosimulation Market Outlook, by Product, Value (US$ Bn), 2019-2032
4.1.1. Key Highlights
4.1.1.1. Software
4.1.1.2. Services
4.2. North America Biosimulation Market Outlook, by Application, Value (US$ Bn), 2019-2032
4.2.1. Key Highlights
4.2.1.1. Drug Development
4.2.1.2. Drug Discovery
4.2.1.3. Other Applications
4.3. North America Biosimulation Market Outlook, by End User, Value (US$ Bn), 2019-2032
4.3.1. Key Highlights
4.3.1.1. Academic and Government Research Institutes
4.3.1.2. Pharmaceutical and Biotech Companies
4.3.1.3. Contract Research Organizations
4.3.1.4. Regulatory Authorities
4.3.1.5. Other End Users
4.4. North America Biosimulation Market Outlook, by Country, Value (US$ Bn), 2019-2032
4.4.1. Key Highlights
4.4.1.1. U.S. Biosimulation Market by Product, Value (US$ Bn), 2019-2032
4.4.1.2. U.S. Biosimulation Market by Application, Value (US$ Bn), 2019-2032
4.4.1.3. U.S. Biosimulation Market End User, Value (US$ Bn), 2019-2032
4.4.1.4. Canada Biosimulation Market by Product, Value (US$ Bn), 2019-2032
4.4.1.5. Canada Biosimulation Market by Application, Value (US$ Bn), 2019-2032
4.4.1.6. Canada Biosimulation Market End User, Value (US$ Bn), 2019-2032
4.4.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Biosimulation Market Outlook, 2019-2032
5.1. Europe Biosimulation Market Outlook, by Product, Value (US$ Bn), 2019-2032
5.1.1. Key Highlights
5.1.1.1. Software
5.1.1.2. Services
5.2. Europe Biosimulation Market Outlook, by Application, Value (US$ Bn), 2019-2032
5.2.1. Key Highlights
5.2.1.1. Drug Development
5.2.1.2. Drug Discovery
5.2.1.3. Other Applications
5.3. Europe Biosimulation Market Outlook, by End User, Value (US$ Bn), 2019-2032
5.3.1. Key Highlights
5.3.1.1. Academic and Government Research Institutes
5.3.1.2. Pharmaceutical and Biotech Companies
5.3.1.3. Contract Research Organizations
5.3.1.4. Regulatory Authorities
5.3.1.5. Other End Users
5.4. Europe Biosimulation Market Outlook, by Country, Value (US$ Bn), 2019-2032
5.4.1. Key Highlights
5.4.1.1. Germany Biosimulation Market by Product, Value (US$ Bn), 2019-2032
5.4.1.2. Germany Biosimulation Market by Application, Value (US$ Bn), 2019-2032
5.4.1.3. Germany Biosimulation Market End User, Value (US$ Bn), 2019-2032
5.4.1.4. U.K. Biosimulation Market by Product, Value (US$ Bn), 2019-2032
5.4.1.5. U.K. Biosimulation Market by Application, Value (US$ Bn), 2019-2032
5.4.1.6. U.K. Biosimulation Market End User, Value (US$ Bn), 2019-2032
5.4.1.7. France Biosimulation Market by Product, Value (US$ Bn), 2019-2032
5.4.1.8. France Biosimulation Market by Application, Value (US$ Bn), 2019-2032
5.4.1.9. France Biosimulation Market End User, Value (US$ Bn), 2019-2032
5.4.1.10. Italy Biosimulation Market by Product, Value (US$ Bn), 2019-2032
5.4.1.11. Italy Biosimulation Market by Application, Value (US$ Bn), 2019-2032
5.4.1.12. Italy Biosimulation Market End User, Value (US$ Bn), 2019-2032
5.4.1.13. Turkey Biosimulation Market by Product, Value (US$ Bn), 2019-2032
5.4.1.14. Turkey Biosimulation Market by Application, Value (US$ Bn), 2019-2032
5.4.1.15. Turkey Biosimulation Market End User, Value (US$ Bn), 2019-2032
5.4.1.16. Russia Biosimulation Market by Product, Value (US$ Bn), 2019-2032
5.4.1.17. Russia Biosimulation Market by Application, Value (US$ Bn), 2019-2032
5.4.1.18. Russia Biosimulation Market End User, Value (US$ Bn), 2019-2032
5.4.1.19. Rest of Europe Biosimulation Market by Product, Value (US$ Bn), 2019-2032
5.4.1.20. Rest of Europe Biosimulation Market by Application, Value (US$ Bn), 2019-2032
5.4.1.21. Rest of Europe Biosimulation Market End User, Value (US$ Bn), 2019-2032
5.4.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Biosimulation Market Outlook, 2019-2032
6.1. Asia Pacific Biosimulation Market Outlook, by Product, Value (US$ Bn), 2019-2032
6.1.1. Key Highlights
6.1.1.1. Software
6.1.1.2. Services
6.2. Asia Pacific Biosimulation Market Outlook, by Application, Value (US$ Bn), 2019-2032
6.2.1. Key Highlights
6.2.1.1. Drug Development
6.2.1.2. Drug Discovery
6.2.1.3. Other Applications
6.3. Asia Pacific Biosimulation Market Outlook, by End User, Value (US$ Bn), 2019-2032
6.3.1. Key Highlights
6.3.1.1. Academic and Government Research Institutes
6.3.1.2. Pharmaceutical and Biotech Companies
6.3.1.3. Contract Research Organizations
6.3.1.4. Regulatory Authorities
6.3.1.5. Other End Users
6.4. Asia Pacific Biosimulation Market Outlook, by Country, Value (US$ Bn), 2019-2032
6.4.1. Key Highlights
6.4.1.1. China Biosimulation Market by Product, Value (US$ Bn), 2019-2032
6.4.1.2. China Biosimulation Market by Application, Value (US$ Bn), 2019-2032
6.4.1.3. China Biosimulation Market End User, Value (US$ Bn), 2019-2032
6.4.1.4. Japan Biosimulation Market by Product, Value (US$ Bn), 2019-2032
6.4.1.5. Japan Biosimulation Market by Application, Value (US$ Bn), 2019-2032
6.4.1.6. Japan Biosimulation Market End User, Value (US$ Bn), 2019-2032
6.4.1.7. South Korea Biosimulation Market by Product, Value (US$ Bn), 2019-2032
6.4.1.8. South Korea Biosimulation Market by Application, Value (US$ Bn), 2019-2032
6.4.1.9. South Korea Biosimulation Market End User, Value (US$ Bn), 2019-2032
6.4.1.10. India Biosimulation Market by Product, Value (US$ Bn), 2019-2032
6.4.1.11. India Biosimulation Market by Application, Value (US$ Bn), 2019-2032
6.4.1.12. India Biosimulation Market End User, Value (US$ Bn), 2019-2032
6.4.1.13. Southeast Asia Biosimulation Market by Product, Value (US$ Bn), 2019-2032
6.4.1.14. Southeast Asia Biosimulation Market by Application, Value (US$ Bn), 2019-2032
6.4.1.15. Southeast Asia Biosimulation Market End User, Value (US$ Bn), 2019-2032
6.4.1.16. Rest of Asia Pacific Biosimulation Market by Product, Value (US$ Bn), 2019-2032
6.4.1.17. Rest of Asia Pacific Biosimulation Market by Application, Value (US$ Bn), 2019-2032
6.4.1.18. Rest of Asia Pacific Biosimulation Market End User, Value (US$ Bn), 2019-2032
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Biosimulation Market Outlook, 2019-2032
7.1. Latin America Biosimulation Market Outlook, by Product, Value (US$ Bn), 2019-2032
7.1.1. Key Highlights
7.1.1.1. Software
7.1.1.2. Services
7.2. Latin America Biosimulation Market Outlook, by Application, Value (US$ Bn), 2019-2032
7.2.1. Key Highlights
7.2.1.1. Drug Development
7.2.1.2. Drug Discovery
7.2.1.3. Other Applications
7.3. Latin America Biosimulation Market Outlook, by End User, Value (US$ Bn), 2019-2032
7.3.1. Key Highlights
7.3.1.1. Academic and Government Research Institutes
7.3.1.2. Pharmaceutical and Biotech Companies
7.3.1.3. Contract Research Organizations
7.3.1.4. Regulatory Authorities
7.3.1.5. Other End Users
7.4. Latin America Biosimulation Market Outlook, by Country, Value (US$ Bn), 2019-2032
7.4.1. Key Highlights
7.4.1.1. Brazil Biosimulation Market by Product, Value (US$ Bn), 2019-2032
7.4.1.2. Brazil Biosimulation Market by Application, Value (US$ Bn), 2019-2032
7.4.1.3. Brazil Biosimulation Market End User, Value (US$ Bn), 2019-2032
7.4.1.4. Mexico Biosimulation Market by Product, Value (US$ Bn), 2019-2032
7.4.1.5. Mexico Biosimulation Market by Application, Value (US$ Bn), 2019-2032
7.4.1.6. Mexico Biosimulation Market End User, Value (US$ Bn), 2019-2032
7.4.1.7. Argentina Biosimulation Market by Product, Value (US$ Bn), 2019-2032
7.4.1.8. Argentina Biosimulation Market by Application, Value (US$ Bn), 2019-2032
7.4.1.9. Argentina Biosimulation Market End User, Value (US$ Bn), 2019-2032
7.4.1.10. Rest of Latin America Biosimulation Market by Product, Value (US$ Bn), 2019-2032
7.4.1.11. Rest of Latin America Biosimulation Market by Application, Value (US$ Bn), 2019-2032
7.4.1.12. Rest of Latin America Biosimulation Market End User, Value (US$ Bn), 2019-2032
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Biosimulation Market Outlook, 2019-2032
8.1. Middle East & Africa Biosimulation Market Outlook, by Product, Value (US$ Bn), 2019-2032
8.1.1. Key Highlights
8.1.1.1. Software
8.1.1.2. Services
8.2. Middle East & Africa Biosimulation Market Outlook, by Application, Value (US$ Bn), 2019-2032
8.2.1. Key Highlights
8.2.1.1. Drug Development
8.2.1.2. Drug Discovery
8.2.1.3. Other Applications
8.3. Middle East & Africa Biosimulation Market Outlook, by End User, Value (US$ Bn), 2019-2032
8.3.1. Key Highlights
8.3.1.1. Academic and Government Research Institutes
8.3.1.2. Pharmaceutical and Biotech Companies
8.3.1.3. Contract Research Organizations
8.3.1.4. Regulatory Authorities
8.3.1.5. Other End Users
8.4. Middle East & Africa Biosimulation Market Outlook, by Country, Value (US$ Bn), 2019-2032
8.4.1. Key Highlights
8.4.1.1. GCC Biosimulation Market by Product, Value (US$ Bn), 2019-2032
8.4.1.2. GCC Biosimulation Market by Application, Value (US$ Bn), 2019-2032
8.4.1.3. GCC Biosimulation Market End User, Value (US$ Bn), 2019-2032
8.4.1.4. South Africa Biosimulation Market by Product, Value (US$ Bn), 2019-2032
8.4.1.5. South Africa Biosimulation Market by Application, Value (US$ Bn), 2019-2032
8.4.1.6. South Africa Biosimulation Market End User, Value (US$ Bn), 2019-2032
8.4.1.7. Egypt Biosimulation Market by Product, Value (US$ Bn), 2019-2032
8.4.1.8. Egypt Biosimulation Market by Application, Value (US$ Bn), 2019-2032
8.4.1.9. Egypt Biosimulation Market End User, Value (US$ Bn), 2019-2032
8.4.1.10. Nigeria Biosimulation Market by Product, Value (US$ Bn), 2019-2032
8.4.1.11. Nigeria Biosimulation Market by Application, Value (US$ Bn), 2019-2032
8.4.1.12. Nigeria Biosimulation Market End User, Value (US$ Bn), 2019-2032
8.4.1.13. Rest of Middle East & Africa Biosimulation Market by Product, Value (US$ Bn), 2019-2032
8.4.1.14. Rest of Middle East & Africa Biosimulation Market by Application, Value (US$ Bn), 2019-2032
8.4.1.15. Rest of Middle East & Africa Biosimulation Market End User, Value (US$ Bn), 2019-2032
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Product vs End User Heatmap
9.2. Manufacturer vs End User Heatmap
9.3. Company Market Share Analysis, 2024
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. Certara, L.P
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. Simulations Plus, Inc.
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. Dassault Systemes SE
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. Schrodinger, Inc
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. Advanced Chemistry Development, Inc.
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. Entelos, Inc.
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. Evidera, Inc.
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. Genedata AG
9.5.8.1. Company Overview
9.5.8.2. Product Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development
9.5.9. Leadscope Inc
9.5.9.1. Company Overview
9.5.9.2. Product Portfolio
9.5.9.3. Financial Overview
9.5.9.4. Business Strategies and Development
9.5.10. Acceryls Inc.
9.5.10.1. Company Overview
9.5.10.2. Product Portfolio
9.5.10.3. Financial Overview
9.5.10.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.